Karsten Witt

President en KW Biotech Consulting LLC .

68 años

Health Technology

Consumer Services

Perfil

Karsten Witt currently works at KW Biotech Consulting LLC, as President from 2013.
Dr. Witt also formerly worked at Topotarget A, as Director in 2011, OSI Pharmaceuticals, Inc., as Senior Vice President-Pharmaceutical Operations, Array BioPharma, Inc., as Vice President-Clinical Sciences from 2011 to 2013, and Black Diamond Therapeutics, Inc., as Chief Medical Officer & VP-Clinical Development from 2021 to 2022.
Dr. Witt received his doctorate degree in 1985 from the University of Copenhagen.

Cargos activos de Karsten Witt

Empresas	Cargo	Inicio
KW Biotech Consulting LLC	President	01/02/2013

Todos los cargos activos de Karsten Witt

Antiguos cargos conocidos de Karsten Witt.

Empresas	Cargo	Fin
BLACK DIAMOND THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	08/09/2020
ARRAY TECHNOLOGIES, INC.	Chief Tech/Sci/R&D Officer	01/01/2013
OSI PHARMACEUTICALS, INC.	Corporate Officer/Principal	-
TOPOTARGET A/S	Director/Board Member	-

Ver el detalle de la experiencia de Karsten Witt.

Formación de Karsten Witt.

University of Copenhagen

Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Karsten Witt.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
BLACK DIAMOND THERAPEUTICS, INC.	Health Technology

Empresas privadas	4
OSI Pharmaceuticals, Inc. OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY.	Health Technology
Array BioPharma, Inc. Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO.	Health Technology
Topotarget A/S Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark.	Health Technology
KW Biotech Consulting LLC

Ver las conexiones de la empresa